Low-dose Interleukin-2 Treatment on Idiopathic Inflammatory Myopathy
NCT04062019
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Inflammatory Myopathy
Interventions
DRUG:
Interleukin-2
Sponsor
Peking University People's Hospital